Annual SGA
$6.73 M
-$1.91 M-22.13%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual SGA is $6.73 million, with the most recent change of -$1.91 million (-22.13%) on December 31, 2023.
- During the last 3 years, NRBO annual SGA has fallen by -$1.12 million (-14.25%).
- NRBO annual SGA is now -35.54% below its all-time high of $10.44 million, reached on December 31, 2017.
Performance
NRBO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.74 M
-$268.00 K-13.33%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly SGA is $1.74 million, with the most recent change of -$268.00 thousand (-13.33%) on September 30, 2024.
- Over the past year, NRBO quarterly SGA has dropped by -$60.00 thousand (-3.33%).
- NRBO quarterly SGA is now -62.76% below its all-time high of $4.68 million, reached on June 30, 2017.
Performance
NRBO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$478.96 M
-$27.73 M-6.15%
September 30, 2024
Summary
- As of February 12, 2025, NRBO TTM SGA is -$478.96 million, with the most recent change of -$27.73 million (-6.15%) on September 30, 2024.
- Over the past year, NRBO TTM SGA has dropped by -$485.69 million (-7218.91%).
- NRBO TTM SGA is now -3765.07% below its all-time high of -$12.39 million.
Performance
NRBO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NRBO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.1% | -3.3% | -7218.9% |
| 3 y3 years | -14.3% | -15.8% | -6157.4% |
| 5 y5 years | +319.2% | -30.2% | -10000.0% |
NRBO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.1% | at low | -32.5% | +20.8% | -58.2% | at low |
| 5 y | 5-year | -23.1% | +149.1% | -32.9% | +225.9% | -182.6% | at low |
| alltime | all time | -35.5% | +3043.9% | -62.8% | +132.1% | -3765.1% | at low |
NeuroBo Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.74 M(-13.3%) | $7.53 M(+1.9%) |
| Jun 2024 | - | $2.01 M(+1.7%) | $7.39 M(+8.3%) |
| Mar 2024 | - | $1.98 M(+9.7%) | $6.82 M(+1.4%) |
| Dec 2023 | $6.73 M(-22.1%) | $1.80 M(+12.6%) | $6.73 M(-1.7%) |
| Sep 2023 | - | $1.60 M(+11.0%) | $6.84 M(-12.0%) |
| Jun 2023 | - | $1.44 M(-23.4%) | $7.77 M(-9.3%) |
| Mar 2023 | - | $1.88 M(-1.7%) | $8.57 M(-0.8%) |
| Dec 2022 | $8.64 M(-1.3%) | $1.92 M(-24.4%) | $8.64 M(-7.2%) |
| Sep 2022 | - | $2.53 M(+13.2%) | $9.31 M(+5.2%) |
| Jun 2022 | - | $2.24 M(+14.4%) | $8.84 M(+3.8%) |
| Mar 2022 | - | $1.96 M(-24.3%) | $8.52 M(-2.7%) |
| Dec 2021 | $8.75 M(+11.5%) | $2.58 M(+24.7%) | $8.75 M(+10.7%) |
| Sep 2021 | - | $2.07 M(+8.2%) | $7.91 M(+3.6%) |
| Jun 2021 | - | $1.91 M(-12.5%) | $7.63 M(+2.6%) |
| Mar 2021 | - | $2.19 M(+26.0%) | $7.44 M(-5.2%) |
| Dec 2020 | $7.85 M(+190.5%) | $1.74 M(-3.3%) | $7.85 M(+66.0%) |
| Sep 2020 | - | $1.79 M(+4.5%) | $4.73 M(-12.9%) |
| Jun 2020 | - | $1.72 M(-33.8%) | $5.43 M(+16.8%) |
| Mar 2020 | - | $2.60 M(-287.6%) | $4.65 M(+72.0%) |
| Dec 2019 | $2.70 M | -$1.38 M(-155.5%) | $2.70 M(-302.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $2.50 M(+165.7%) | -$1.33 M(-8.9%) |
| Jun 2019 | - | $939.00 K(+44.2%) | -$1.47 M(-967.5%) |
| Mar 2019 | - | $651.00 K(-112.0%) | $169.00 K(-89.5%) |
| Dec 2018 | $1.60 M(-84.6%) | -$5.42 M(-329.3%) | $1.60 M(-81.1%) |
| Sep 2018 | - | $2.36 M(-8.2%) | $8.51 M(+3.8%) |
| Jun 2018 | - | $2.57 M(+23.3%) | $8.20 M(-20.4%) |
| Mar 2018 | - | $2.09 M(+40.3%) | $10.30 M(-1.3%) |
| Dec 2017 | $10.44 M(+75.3%) | $1.49 M(-27.5%) | $10.44 M(-8.0%) |
| Sep 2017 | - | $2.05 M(-56.2%) | $11.34 M(+5.4%) |
| Jun 2017 | - | $4.68 M(+110.4%) | $10.76 M(+50.9%) |
| Mar 2017 | - | $2.22 M(-6.9%) | $7.13 M(+19.7%) |
| Dec 2016 | $5.96 M(+87.5%) | $2.39 M(+63.0%) | $5.96 M(+29.1%) |
| Sep 2016 | - | $1.47 M(+39.5%) | $4.61 M(+11.3%) |
| Jun 2016 | - | $1.05 M(+0.1%) | $4.14 M(+10.5%) |
| Mar 2016 | - | $1.05 M(+0.3%) | $3.75 M(+18.1%) |
| Dec 2015 | $3.18 M(+1384.6%) | $1.05 M(+5.0%) | $3.18 M(+49.2%) |
| Sep 2015 | - | $997.00 K(+51.5%) | $2.13 M(+88.0%) |
| Jun 2015 | - | $658.00 K(+38.5%) | $1.13 M(+138.5%) |
| Mar 2015 | - | $475.00 K | $475.00 K |
| Dec 2014 | $214.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual SGA?
- What is the all time high annual SGA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual SGA year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly SGA year-on-year change?
- What is NeuroBo Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM SGA year-on-year change?
What is NeuroBo Pharmaceuticals annual SGA?
The current annual SGA of NRBO is $6.73 M
What is the all time high annual SGA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual SGA is $10.44 M
What is NeuroBo Pharmaceuticals annual SGA year-on-year change?
Over the past year, NRBO annual SGA has changed by -$1.91 M (-22.13%)
What is NeuroBo Pharmaceuticals quarterly SGA?
The current quarterly SGA of NRBO is $1.74 M
What is the all time high quarterly SGA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly SGA is $4.68 M
What is NeuroBo Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, NRBO quarterly SGA has changed by -$60.00 K (-3.33%)
What is NeuroBo Pharmaceuticals TTM SGA?
The current TTM SGA of NRBO is -$478.96 M
What is the all time high TTM SGA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM SGA is -$12.39 M
What is NeuroBo Pharmaceuticals TTM SGA year-on-year change?
Over the past year, NRBO TTM SGA has changed by -$485.69 M (-7218.91%)